We hypothesized that measurement of plasma CT-proET-1 would carry additional prognostic value in a population of patients with CHF, beyond other generally accepted prognostic markers, including clinical measures of CHF severity and plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP). Here, NPPB is linked to congestive heart failure.